<DOC>
	<DOCNO>NCT00522808</DOCNO>
	<brief_summary>The purpose study : - determine safety tolerability multiple dose A-831 various dos - determine multiple dose A-831 distribute bloodstream - determine A-831 reduce amount Hepatitis C virus blood</brief_summary>
	<brief_title>A Study PK , Safety Antiviral Activity A-831 HCV Carriers</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>Volunteers male race age 1860 year BMI 18 32 kg/m2 time screen medical Volunteers give write informed consent participate study Volunteers willing able comply protocol study procedures Volunteers diagnosis chronic hepatitis C infection good health ( history Hepatitis C infection ) Voulnteers concurrent medical condition take concurrent medication</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>HCV</keyword>
	<keyword>antiviral</keyword>
	<keyword>PK</keyword>
	<keyword>Safety</keyword>
</DOC>